Characteristics of revascularization treatment for arteriosclerosis obliterans in patients with and without hemodialysis

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2426-2433

  Hoshino, Junichi ^a   Fujimoto, Yo ^a   Naruse, Yoshihiro ^a   Hasegawa, Eiko ^a   Suwabe, Tatsuya ^a   Sawa, Naoki ^a   Takemoto, Fumi ^a   Ishiwata, Sugao ^a   Ohno, Minoru ^a   Ubara, Yoshifumi ^a   Yamagata, Kunihiro ^b   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Angioplasty; Bypass surgery; Hemodialysis outcomes; Peripheral arterial disease

Indexed keywords

ADULT; AGED; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT PATENCY; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; INFECTION; LEG AMPUTATION; LEG REVASCULARIZATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

AGED; AMPUTATION; ANGIOPLASTY; ARTERIOSCLEROSIS OBLITERANS; CHI-SQUARE DISTRIBUTION; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERLIPIDEMIAS; ISCHEMIA; JAPAN; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LINEAR MODELS; LOWER EXTREMITY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 78349248263     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0910     Document Type: Article

References (21)

1. Wolfle KD, Bruijnen H, Leoprecht H, Rümenapf G, Schweiger H, Grabitz K, et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: Results of a multi-centre comparative analysis. Eur J Vasc Endovasc Surg 2005; 25: 229-234.
2. van der Zaag ES, Legemate DA, Prins MH, Reekers JA, Jacobs MJ. Angioplasty or bypass for superficial femoral artery disease? A randomized controlled trial. Eur J Vasc Endovasc Surg 2004; 28: 132-137.
3. Alber M, Romiti M, Brochado-Neto FC, Pereira CAB. Metaanalysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg 2005; 42: 449-455.
4. Papavassiliou VG, Walker SR, Bolia A, Fishwick G, London N. Techniques for endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 2003; 25: 125-130.
5. Black JH 3rd, LaMuraglia GM, Kwolek CJ, Brewster DC, Watkins MT, Cambria RP. Contemporary results of angioplasty-based infrainguinal percutaneous interventions. J Vasc Surg 2005; 42: 932-939.
6. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al; BASIL trial participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): Multicentre, randomized controlled trial. Lancet 2005; 366: 1925-1934.
7. Kimura H, Miyata T, Sato O, Furuya T, Iyori K, Shigematsu H. Infrainguinal arterial reconstruction for limb salvage in patients with end-stage renal disease. Eur J Vasc Endovasc Surg 2003; 25: 29-34.
8. Hakaim AG, Gordon JK, Scott TE. Early outcome of in situ femorotibial reconstruction among patients with diabetes alone versus diabetes and end-stage renal failure. J Vasc Surg 2003; 27: 29-34.
9. Ramdev P, Rayan SS, Sheahan M, Hamdan AD, Logerfo FW, Akbari CM, et al. A decade of experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002; 36: 969-974.
10. Meyerson SL, Skelly CL, Curi MA, Desai TR, Katz D, Bassiouny HS, et al. Long-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal failure. J Vasc Surg 2001; 34: 27-33.
11. Aulivola B, Gargiulo M, Bessoni M, Rumolo A, Stella A. Infrapopliteal angioplasty for limb salvage in the setting of renal failure: Do results justify its use? Ann Vasc Surg 2005; 19: 762-768.
12. Graziani L, Silvestro A, Bertone V, Manara E, Alicandri A, Parrinello G, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 2007; 22: 1144-1149.
13. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised edition. J Vasc Surg 1997; 26: 517-538.
14. Trans Atlantic Inter-Consensus (TASC). Management of peripheral artery disease (PAD). J Vasc Surg 2000; 31(Suppl 1 Pt 2): S1-S278.
15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
16. Hoshino J, Ubara Y, Ohara K, Ohta E, Suwabe T, Higa Y, et al. Changes in the activities of daily living (ADL) in relation to the level of amputation of patients undergoing lower extremity amputation for arteriosclerosis obliterans (ASO). Circ J 2008; 72: 1495-1498.
17. Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, Maezawa A, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003; 14: 1591-1598.
18. Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: Requirements for diagnostics. Am J Kidney Dis 2002; 40: 472-479.
19. Duffield RGM, Lewis B, Miller NE, Jamieson CW, Brunt JN, Colchester AC. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis: A randomized controlled trial. Lancet 1983; 2: 639-642.
20. Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H, et al. Importance of lipid levels in elderly diabetic individuals: Baseline characteristics and 1-year survey of cardiovascular events. Circ J 2008; 72: 218-225.
21. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomized controlled trial. Lancet 2002; 360: 7-22.